Successful farm trials for CytoGard

The innovative CytoGard product, designed and developed using advanced technologies, underwent extensive farm trials to validate its efficacy and quality. These trials were conducted at two different scales to ensure a comprehensive evaluation of the product's performance under real livestock farming conditions

In the first phase, farm trials were conducted on a small population of 800 broiler chickens at the Ferdowsi University of Mashhad farm. This preliminary phase allowed an initial assessment of Cytoguard’s effects on improving poultry health and performance.

To further increase credibility and validation, trials on a larger scale were also performed on a 15,000-head farm under the close supervision of the SANA Research Institute in Tehran. This phase aimed to evaluate the product’s performance in operational, real-world farm conditions and to analyze results on a broader scale.

The results from these two farm trial phases clearly demonstrated CytoGard’s success in enhancing broiler chicken performance. Particularly, the positive effects of the product on increasing productivity and poultry health not only confirmed its efficacy but also strengthened its scientific credibility.

NikaBiotech, relying on these valuable results, is committed to continuing the development and improvement of its products based on science and modern technologies and to making significant strides in advancing the country’s livestock and poultry industry.